| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 654435 | 33214 | GENOXAL 50 mg COMPRIMIDOS RECUBIERTOS | GENOXAL 50 mg COMPRIMIDOS RECUBIERTOS , 20 comprimidos | 50 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/33214/33214_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/33214/33214_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 7980 | 7980 | 1959-12-01 | 1 | 1 | 1 | 1959-12-01 | 2012-07-09 | 1 | 2013-01-03 | 762955, 663199, 672023 | View Edit Delete | |||||||||||
| 656340 | 68153 | XAZAL 0,5 mg/ml SOLUCION ORAL | XAZAL 0,5 mg/ml SOLUCION ORAL, 1 frasco de 200 ml | 0,5 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68153/68153_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68153/68153_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21333 | 21333 | 2006-11-08 | 1 | 1 | 1 | 2006-11-08 | 2006-11-08 | 1 | 2011-05-04 | View Edit Delete | ||||||||||||
| 704070 | 79116 | BRONCHOSTOP ANTITUSIVO Y EXPECTORANTE SOLUCION ORAL | BRONCHOSTOP ANTITUSIVO Y EXPECTORANTE SOLUCION ORAL , 1 frasco de 200 ml | 120 mg/15 ml + 830 mg/15 ml | 6 | 200 | 26 | 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79116/79116_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79116/79116_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 14258 | 88108 | 2014-10-20 | 1 | 1 | 1 | 2014-10-20 | 2014-10-30 | 1 | 2015-10-06 | View Edit Delete | ||||||||||||
| 706414 | 100133034 | TOUJEO 300 UNIDADES/ML SOLOSTAR SOLUCION INYECTABLE EN PLUMA PRECARGADA | TOUJEO 300 UNIDADES/ML SOLOSTAR SOLUCION INYECTABLE EN PLUMA PRECARGADA, 3 plumas 1,5 ml | 300 U/ml inyectable 1,5 ml | 66 | 3 | 49 | 3 plumas 1,5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/100133034/100133034_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/100133034/100133034_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42153 | 40842 | 2015-05-11 | 1 | 1 | 1 | 2015-05-11 | 2015-05-11 | 1 | 2016-02-15 | View Edit Delete | ||||||||||||
| 712684 | 81246 | GELODOL CREMA | GELODOL CREMA Tubo de 90 g | 100 mg/g | 44 | 90 | 21 | Tubo de 90 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81246/81246_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81246/81246_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 34727 | 4115 | 2016-09-26 | 1 | 1 | 1 | 2016-09-29 | 2016-09-26 | 1 | 2022-07-27 | View Edit Delete | ||||||||||||
| 719066 | 82434 | TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA | TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 3,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82434/82434_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82434/82434_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 10255 | 2018-03-02 | 1 | 1 | 1 | 2018-03-02 | 2018-03-02 | 1 | 2019-10-11 | View Edit Delete | ||||||||||||
| 719073 | 82435 | TOVEDESO 7 MG COMPRIMIDOS DE LIBERACION PROLONGADA | TOVEDESO 7 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 7 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82435/82435_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82435/82435_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 10255 | 2018-03-02 | 1 | 1 | 1 | 2018-03-02 | 2018-03-02 | 1 | 2019-10-11 | View Edit Delete | ||||||||||||
| 720071 | 1171218001 | RYDAPT 25 MG CAPSULAS BLANDAS | RYDAPT 25 MG CAPSULAS BLANDAS, 56 cápsulas | 25 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171218001/1171218001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171218001/1171218001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 28642 | 1945 | 2017-10-30 | 1 | 1 | 1 | 2017-10-31 | 2017-12-13 | 1 | 2019-03-15 | View Edit Delete | ||||||||||||
| 720416 | 81246 | GELODOL CREMA | GELODOL CREMA Tubo de 50 g | 100 mg/g | 44 | 50 | 21 | Tubo de 50 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81246/81246_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81246/81246_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 34727 | 4115 | 2016-09-26 | 1 | 1 | 1 | 2016-09-29 | 2018-01-15 | 1 | 2019-12-30 | View Edit Delete | ||||||||||||
| 721967 | 83172 | KALOBA JARABE | KALOBA JARABE, 1 frasco de 100 ml | 2,67 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83172/83172_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83172/83172_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 867 | 39858 | 2018-06-05 | 1 | 1 | 1 | 2018-06-06 | 2018-06-05 | 1 | 2019-07-05 | View Edit Delete | ||||||||||||
| 724541 | 83759 | TRAMADOL ANDROMACO 100 MG/ML SOLUCION ORAL EFG | TRAMADOL ANDROMACO 100 MG/ML SOLUCION ORAL EFG 1 Frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 Frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83759/83759_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83759/83759_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23666 | 23666 | 2019-01-11 | 1 | 1 | 1 | 2019-01-12 | 2019-01-11 | 1 | 2023-05-31 | View Edit Delete | ||||||||||||
| 724639 | 1181270003 | SEMGLEE 100 UNIDADES/ML SOLUCION INYECTABLE EN PLUMA PRECARGADA | Semglee 100 unidades/ml solucion inyectable en pluma precargada, 5 plumas de 3 ml | 100 U/ml inyectable 3 ml | 66 | 5 | 49 | 5 plumas de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181270003/1181270003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181270003/1181270003_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 44114 | 44571 | 2019-02-25 | 1 | 1 | 1 | 2019-02-26 | 2019-02-25 | 1 | 2020-06-11 | View Edit Delete | ||||||||||||
| 725638 | 84020 | ACIDO FUSIDICO REDOXFARMA 20 MG/G CREMA | ACIDO FUSIDICO REDOXFARMA 20 MG/G CREMA, 1 tubo de 15 g | 20 mg/g | 44 | 15 | 21 | 1 tubo de 15 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84020/84020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84020/84020_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30674 | 30674 | 2019-04-08 | 1 | 1 | 1 | 2024-09-13 | 2024-09-13 | 1 | 2024-09-13 | View Edit Delete | ||||||||||||
| 725865 | 84165 | AMBROXOL STADA 6 MG/ML JARABE EFG | AMBROXOL STADA 6 MG/ML JARABE EFG 1 frasco de 250 ml | 6 mg/ml | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84165/84165_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84165/84165_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2019-05-24 | 1 | 1 | 1 | 2019-05-25 | 2019-05-24 | 1 | 2019-12-05 | View Edit Delete | ||||||||||||
| 726080 | 84238 | LASEA 80 MG CAPSULAS BLANDAS | LASEA 80 MG CAPSULAS BLANDAS, 28 cápsulas | 80 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84238/84238_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84238/84238_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2019-06-11 | 1 | 1 | 1 | 2019-06-12 | 2019-06-11 | 1 | 2019-12-17 | View Edit Delete | ||||||||||||
| 726081 | 84238 | LASEA 80 MG CAPSULAS BLANDAS | LASEA 80 MG CAPSULAS BLANDAS, 56 cápsulas | 80 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84238/84238_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84238/84238_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2019-06-11 | 1 | 1 | 1 | 2019-06-12 | 2019-06-11 | 1 | 2023-05-19 | View Edit Delete | ||||||||||||
| 727474 | 84690 | DEKRISTOLAN 20.000 UI CAPSULAS BLANDAS | DEKRISTOLAN 20.000 UI CAPSULAS BLANDAS 4 cápsulas | 20.000 UI | 5 | 4 | 43 | 4 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84690/84690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84690/84690_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71281 | 71281 | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2021-06-01 | View Edit Delete | ||||||||||||
| 728062 | 84901 | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES 14 cápsulas | 90 mg/50 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84901/84901_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84901/84901_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2022-11-08 | View Edit Delete | ||||||||||||
| 728063 | 84901 | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES 42 cápsulas | 90 mg/50 mg | 5 | 42 | 43 | 42 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84901/84901_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84901/84901_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2023-09-01 | View Edit Delete | ||||||||||||
| 728064 | 84901 | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES 84 cápsulas | 90 mg/50 mg | 5 | 84 | 43 | 84 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84901/84901_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84901/84901_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2025-10-03 | View Edit Delete | ||||||||||||
| 730628 | R-0600 | MICROGYNON 0,15 MG/0,03 MG COMPRIMIDOS RECUBIERTOS | MICROGYNON 0,15 MG/0,03 MG COMPRIMIDOS RECUBIERTOS, 21 comprimidos | 0,15 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26523 | 43579 | 2021-03-26 | 1 | 1 | 1 | 2021-03-27 | 2021-03-26 | 1 | 2021-05-05 | View Edit Delete | ||||||||||||
| 731904 | 86310 | METILPREDNISOLONA CINFA 1 MG/G EMULSION CUTANEA | METILPREDNISOLONA CINFA 1 MG/G EMULSION CUTANEA, 1 tubo de 50 g | 1 mg/g | 44 | 50 | 21 | 1 tubo de 50 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86310/86310_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86310/86310_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2021-10-08 | 1 | 1 | 1 | 2021-10-09 | 2021-10-08 | 1 | 2025-03-13 | View Edit Delete | ||||||||||||
| 762095 | 88629 | VINORELBINA ACCORD 20 MG CAPSULA BLANDA EFG | VINORELBINA ACCORD 20 MG CAPSULA BLANDA EFG, 1 cápsula | 20 mg | 5 | 1 | 43 | 1 cápsula | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88629/88629_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88629/88629_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2023-02-10 | 1 | 1 | 1 | 2023-02-11 | 2023-02-10 | 1 | 2025-10-13 | View Edit Delete | ||||||||||||
| 762096 | 88630 | VINORELBINA ACCORD 30 MG CAPSULA BLANDA EFG | VINORELBINA ACCORD 30 MG CAPSULA BLANDA EFG, 1 cápsula | 30 mg | 5 | 1 | 43 | 1 cápsula | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88630/88630_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88630/88630_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2023-02-10 | 1 | 1 | 1 | 2023-02-11 | 2023-02-10 | 1 | 2025-10-13 | View Edit Delete | ||||||||||||
| 762538 | 88795 | BETADINE 10 MG/ML SOLUCION PARA ENJUAGUE BUCAL | BETADINE 10 MG/ML SOLUCION PARA ENJUAGUE BUCAL, 1 frasco de 200 ml | 10 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88795/88795_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88795/88795_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67965 | 13592 | 2023-04-17 | 1 | 1 | 1 | 2023-04-18 | 2023-04-17 | 1 | 2024-07-29 | View Edit Delete | ||||||||||||
| 764295 | 89300 | NINTEDANIB STADA 100 MG CÁPSULAS BLANDAS EFG | NINTEDANIB STADA 100 MG CÁPSULAS BLANDAS EFG, 60 cápsulas | 100 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89300/89300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89300/89300_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2026-03-02 | View Edit Delete | ||||||||||||
| 764296 | 89299 | NINTEDANIB STADA 150 MG CÁPSULAS BLANDAS EFG | NINTEDANIB STADA 150 MG CÁPSULAS BLANDAS EFG, 60 cápsulas | 150 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89299/89299_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89299/89299_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2026-03-02 | View Edit Delete | ||||||||||||
| 764321 | 89352 | REVISEA 80 MG CÁPSULAS BLANDAS | REVISEA 80 MG CÁPSULAS BLANDAS, 30 cápsulas | 80 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89352/89352_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89352/89352_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1534 | 1534 | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2024-02-15 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 764504 | 89430 | NINTEDANIB TEVA 100 MG CAPSULAS BLANDAS EFG | NINTEDANIB TEVA 100 MG CAPSULAS BLANDAS EFG, 60 cápsulas | 100 mg | 110 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89430/89430_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89430/89430_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2024-03-08 | 1 | 1 | 1 | 2024-03-09 | 2024-03-08 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 764505 | 89431 | NINTEDANIB TEVA 150 MG CAPSULAS BLANDAS EFG | NINTEDANIB TEVA 150 MG CAPSULAS BLANDAS EFG, 60 cápsulas | 150 mg | 110 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89431/89431_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89431/89431_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2024-03-08 | 1 | 1 | 1 | 2024-03-09 | 2024-03-08 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 765076 | 957700000IP | TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA | TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 3,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10489 | 41972 | 2024-06-03 | 1 | 1 | 1 | 2024-06-04 | 2024-06-03 | 1 | 2025-02-03 | View Edit Delete | ||||||||||||
| 765077 | 957710000IP | TOVEDESO 7 MG COMPRIMIDOS DE LIBERACION PROLONGADA | TOVEDESO 7 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 7 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10489 | 41972 | 2024-06-03 | 1 | 1 | 1 | 2024-06-04 | 2024-06-03 | 1 | 2025-02-03 | View Edit Delete | ||||||||||||
| 765534 | 103260036 | STALEVO 175 MG/43,75 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | STALEVO 175 MG/43,75 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 175 mg/43,75 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/103260036/103260036_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/103260036/103260036_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42344 | 43535 | 2024-08-02 | 1 | 1 | 1 | 2024-08-03 | 2024-08-02 | 1 | 2025-02-18 | View Edit Delete | ||||||||||||
| 765628 | 89785 | MIBAC 10 MG/G + 30 MG/G GEL | MIBAC 10 MG/G + 30 MG/G GEL, 1 Tubo de 30 g | 10 mg/g + 30 mg/g | 44 | 30 | 21 | 1 Tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89785/89785_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89785/89785_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71281 | 71281 | 2024-08-22 | 1 | 1 | 1 | 2024-08-23 | 2024-08-22 | 1 | 2025-04-14 | View Edit Delete | ||||||||||||
| 765629 | 89785 | MIBAC 10 MG/G + 30 MG/G GEL | MIBAC 10 MG/G + 30 MG/G GEL, 1 tubo de 60 g | 10 mg/g + 30 mg/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89785/89785_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89785/89785_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71281 | 71281 | 2024-08-22 | 1 | 1 | 1 | 2024-08-23 | 2024-08-22 | 1 | 2025-04-14 | View Edit Delete | ||||||||||||
| 766339 | 89969 | NINTEDANIB ZENTIVA 100 MG CAPSULAS BLANDAS EFG | NINTEDANIB ZENTIVA 100 MG CAPSULAS BLANDAS EFG, 60 cápsulas | 100 mg | 110 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89969/89969_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89969/89969_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8183 | 69439 | 2025-06-23 | 1 | 1 | 1 | 2025-06-23 | 2025-06-23 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 766341 | 89970 | NINTEDANIB ZENTIVA 150 MG CAPSULAS BLANDAS EFG | NINTEDANIB ZENTIVA 150 MG CAPSULAS BLANDAS EFG, 60 cápsulas | 150 mg | 110 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89970/89970_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89970/89970_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8183 | 69439 | 2025-06-23 | 1 | 1 | 1 | 2025-06-23 | 2025-06-23 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 766522 | 90026 | NINTEDANIB EUGIA 100 MG CÁPSULAS BLANDAS EFG | NINTEDANIB EUGIA 100 MG CÁPSULAS BLANDAS EFG, 60 cápsulas | 100 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90026/90026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90026/90026_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | 16109 | 2025-01-15 | 1 | 1 | 1 | 2025-01-15 | 2025-01-15 | 1 | 2026-02-25 | View Edit Delete | ||||||||||||
| 766525 | 90027 | NINTEDANIB EUGIA 150 MG CÁPSULAS BLANDAS EFG | NINTEDANIB EUGIA 150 MG CÁPSULAS BLANDAS EFG, 60 cápsulas | 150 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90027/90027_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90027/90027_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | 16109 | 2025-01-15 | 1 | 1 | 1 | 2025-01-15 | 2025-01-15 | 1 | 2026-02-25 | View Edit Delete | ||||||||||||
| 766719 | 90078 | AZERIX 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | AZERIX 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 23 g (120 aplicaciones) | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 23 g (120 aplicaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90078/90078_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90078/90078_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 587 | 587 | 2025-01-20 | 1 | 1 | 1 | 2025-01-21 | 2025-01-20 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 767377 | 114979009 | OFEV 25 MG CAPSULAS BLANDAS | OFEV 25 MG CAPSULAS BLANDAS, 60 cápsulas | 25 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114979009/114979009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114979009/114979009_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5126 | 470 | 2025-04-03 | 1 | 1 | 1 | 2025-04-04 | 2025-04-03 | 1 | 2026-04-13 | View Edit Delete | ||||||||||||
| 767894 | 957700000IP1 | TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA | TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 3,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/957700000IP1/957700000IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10489 | 17193 | 2025-06-02 | 1 | 1 | 1 | 2025-06-03 | 2025-06-02 | 1 | 2026-03-17 | View Edit Delete | ||||||||||||
| 767895 | 957710000IP1 | TOVEDESO 7 MG COMPRIMIDOS DE LIBERACION PROLONGADA | TOVEDESO 7 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 7 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/957710000IP1/957710000IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10489 | 17193 | 2025-06-02 | 1 | 1 | 1 | 2025-06-03 | 2025-06-02 | 1 | 2026-03-17 | View Edit Delete | ||||||||||||
| 768345 | 90524 | AVATOP 1 MG/G EMULSIÓN CUTÁNEA | AVATOP 1 MG/G EMULSIÓN CUTÁNEA, 50 g | 1 mg/g | 44 | 50 | 21 | 50 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90524/90524_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90524/90524_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71281 | 71281 | 2025-08-28 | 1 | 1 | 1 | 2025-08-29 | 2025-08-28 | 1 | 2026-01-13 | View Edit Delete | ||||||||||||
| 769704 | 957700000IP3 | TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA | TOVEDESO 3,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 3,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/957700000IP3/957700000IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10489 | 23628 | 2026-01-20 | 1 | 1 | 1 | 2026-01-21 | 2026-01-20 | 1 | 2026-03-11 | View Edit Delete | ||||||||||||
| 769705 | 957710000IP3 | TOVEDESO 7 MG COMPRIMIDOS DE LIBERACION PROLONGADA | TOVEDESO 7 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 7 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/957710000IP3/957710000IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10489 | 23628 | 2026-01-20 | 1 | 1 | 1 | 2026-01-21 | 2026-01-20 | 1 | 2026-03-11 | View Edit Delete | ||||||||||||
| 769967 | 1181270003IP | SEMGLEE 100 UNIDADES/ML SOLUCION INYECTABLE EN PLUMA PRECARGADA | SEMGLEE 100 UNIDADES/ML SOLUCION INYECTABLE EN PLUMA PRECARGADA, 5 plumas de 3 ml | 100 U/ml inyectable 3 ml | 66 | 5 | 49 | 5 plumas de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181270003IP/1181270003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181270003IP/1181270003IP_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 44114 | 23628 | 2026-02-18 | 1 | 1 | 1 | 2026-02-19 | 2026-02-18 | 1 | 2026-04-14 | View Edit Delete | ||||||||||||
| 804633 | 62662 | ADVENTAN 1 mg/g EMULSION CUTANEA | ADVENTAN 1 mg/g EMULSION CUTANEA , 1 tubo de 50 g | 1 mg/g | 44 | 50 | 21 | 1 tubo de 50 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62662/62662_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62662/62662_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8764 | 34965 | 1999-07-01 | 1 | 1 | 1 | 2014-11-17 | 2014-11-17 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 843763 | 65978 | NAVELBINE 20 mg CAPSULAS BLANDAS | NAVELBINE 20 mg CAPSULAS BLANDAS, 1 cápsula | 20 mg | 5 | 1 | 43 | 1 cápsula | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65978/65978_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65978/65978_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2219 | 2219 | 2004-04-05 | 1 | 1 | 1 | 2004-04-06 | 2004-04-05 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 843797 | 65979 | NAVELBINE 30 mg CAPSULAS BLANDAS | NAVELBINE 30 mg CAPSULAS BLANDAS, 1 cápsula | 30 mg | 5 | 1 | 43 | 1 cápsula | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65979/65979_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65979/65979_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2219 | 2219 | 2004-04-01 | 1 | 1 | 1 | 2004-04-06 | 2004-04-01 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 957449 | 56108 | VEPESID 100 mg CAPSULAS BLANDAS | VEPESID 100 mg CAPSULAS BLANDAS , 10 cápsulas | 100 mg | 5 | 10 | 43 | 10 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56108/56108_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56108/56108_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 25535 | 2495 | 1984-07-01 | 1 | 1 | 1 | 1984-07-01 | 1987-06-01 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 962712 | 56488 | VEPESID 50 mg CAPSULAS BLANDAS | VEPESID 50 mg CAPSULAS BLANDAS , 20 cápsulas | 50 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56488/56488_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56488/56488_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 25535 | 2495 | 1986-04-01 | 1 | 1 | 1 | 1986-04-01 | 1986-04-01 | 1 | 2011-10-18 | View Edit Delete |